Theories on the Pathogenesis of Depigmentation Immune Hypothesis

Vitiligo: A Monograph on the Basic and Clinical Science

Volumn , Issue , 2008, Pages 129-135

  Bystryn, Jean Claude ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957375626     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470760116.ch15     Document Type: Chapter

References (29)

1. Al Badri, A.M.T., Foulis, A.K., Todd, P.M. et al. (1993a) Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. Journal of Pathology 169,203-206.
2. Al Badri, A.M.T., Todd, P.M., Gariochi, J.J. et al. (1993b) An immunohistological study of cutaneous lymphocytes in vitiligo. Journal of Pathology 170,149-155.
3. Austin, L.M., Boissy, R.E., Jacobson, B.S. & Smith, J.R. Jr (1992) The detection of melanocyte autoantibodies in the Smyth chicken model for vitiligo. Clinical Immunology and Immunopathology 64,112-120.
4. Baharav, E., Merimsli, O., Shoenfeld, Y. et al. (1996) Tyrosinase as an autoantigen in patients with vitiligo. Clinical and Experimental Immunology 105,84-88.
5. Boissy, R.E., Lamont, S.J. & Smyth, J.R. Jr (1984) Persistence of abnormal melanocytes in immunosuppressed chickens of the autoimmune DAM line. Cell Tissue Research 235, 663-668.
6. Bystryn, J.C. (1997) Immune Mechanisms in Vitiligo. Clinics in Dermatology 15,853-861.
7. Bystryn, J.-C. & Naughton, G.K. (1985) The significance of vitiligo antibodies, journal of Dermatology 12,1-9.
8. Bystryn, J.C. & Xie, Z. (1998) Neoplastic hypomelanoses. In: The Pigmentary System: Physiology and Pathophysiology (eds J.J.Nordlund, R.E.Boissy, V.J.Hearing, R.A.King & J.P.Ortonne), pp. 647-662, Oxford University Press, New York.
9. Cui, J., Shen, L. & Wang, G. (1991) Role of hair follicles in the repigmentation of vitiligo. Journal of Investigative Dermatology 97,410-416.
10. Cui, J., Harning, R., Henn, M. et al. (1992) Identification of pigment cell antigens defined by vitiligo antibodies, Journal of Investigative Dermatology 98,162-165.
11. Cui, J. Arita, Y. & Bystryn, J.C. (1993) Cytolytic antibodies to melanocytes in vitiligo. Journal of Investigative Dermatology 100,812-815.
12. Cui, J., Arita, Y. & Bystryn, J.-C. (1995) Characterization of vitiligo antigens. Pigment Cell Research 8,53-59.
13. Fishman, P., Azizi, E., Shoenfeld, Y. et al. (1993) Vitiligo autoantibodies are effective against melanoma. Cancer 72,2365-2369.
14. Gilhar, A., Zelickson, B., Ulman, Y. & Etzioni, A. (1995) In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo. Journal of Investigative Derma-tology 105,683-686.
15. Hann, S.K., Park, Y.-K., Lee, K.-G., Choi, E.H. & Im, S. (1992) Epidermal changes in active vitiligo. Journal of Dermatology 19,217-222.
16. Hann, S.-K., Chen, D.L. & Bystryn, J.-C. (1997) Systemic steroids suppress antimelanocyte antibodies in vitiligo. Journal of Cutaneous Medicine and Surgery 1,193195.
17. Hara, I., Takechi, Y. & Houghton, A.N. (1995) Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. Journal of Experimental Medicine 182,1609-1614.
18. Harning, R., Cui, J. & Bystryn, J.-C. (1991) Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. Journal of Investigative Derma-tology 97,1078-1080.
19. Kemp, E.H., Gawkrodger, D.J., MacNeil, S., Watson, P.F. & Weetman, A. (1997) Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay. Journal of Investigative Dermatology 109, 69-73.
20. Le Poole, I.C., Van den Wijngaard, R.M., Westerhof, W. & Das, P.K. (1996) Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappear-ance. American Journal of Pathology 148,1219-1228.
21. Mitchell, M.S., Nordlund, J.J. & Lerner, A.B. (1980) Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi, or melanoma. Journal of Investigative Dermatology 75,144.
22. Naughton, G.K., Eisinger, M. & Bystryn, J.-C. (1983) Antibodies to normal human melanocytes in vitiligo. Journal of Experimental Medicine 158,246-251.
23. Naughton, G.K., Mahaffey, M. & Bystryn, J.-C. (1986a) Antibodies to surface antigens of pigmented cells in animals with vitiligo. Proceedings of the Society for Experimental Biology and Medicine 181,423-426.
24. Naughton, G.K., Reggiardo, M.D. & Bystryn, J.-C. (1986b) Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. Journal of the American Academy of Dermatology 15,978-981.
25. Norris, D.A., Capin, L., Muglia, J.J .et al. (1988) Enhanced susceptibility of melanocytes of different immunologic effector mechanisms in vitro: potential mechanisms for postin- flammatory hypopigmentation and vitiligo. Pigment Cell Research Supplement 1, 113-123.
26. Song, Y.H., Connor, E., Li, Y. et al. (1994) The role of tyrosinase in autoimmune vitiligo. Lancet 344,1049-1052.
27. Tobin, D J. & Bystryn, J.-C. (1996) Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Research 9,304-310.
28. Yu, H.S., Kao, C.H. & Yu, C.L. (1993) Co-existence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo. Journal of Investigative Dermatology 100,823-828.
29. Xie, Z. & Bystryn, J.-C. (1996) Anti-tyrosinase antibodies in vitiligo. Journal of Investigative Dermatology 106,938.